A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for Overweight
60 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025
DM Clinical Research - Indianapolis
Clinical research site in Indianapolis, Indiana
Part of DM Clinical Research
As of July 2026, 2 paid clinical trials are recruiting at DM Clinical Research - Indianapolis in Indianapolis, Indiana. Active studies at this site cover conditions such as Overweight, Obesity and Chronic Obstructive Pulmonary Disease (COPD). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at DM Clinical Research - Indianapolis (2)
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for Chronic Obstructive Pulmonary Disease (COPD)
12 locations incl. Phoenix
Sponsor: Expedition Therapeutics, Inc
Sex: All·Age: 40 - 85
Code: NCT07684820·Phase 2·Recruiting·Listed Jul 6, 2026
More research sites in Indianapolis
- Indiana University (100 trials)
- Riley Hospital for Children (67 trials)
- Indiana University School of Medicine (54 trials)
- Indiana University/Melvin and Bren Simon Cancer Center (33 trials)
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center (27 trials)
- Indiana University Health (22 trials)
- Indiana University Health University Hospital (20 trials)
- Saint Catherine Hospital (20 trials)
- Community Health Network (19 trials)
- Indiana University Hospital (17 trials)
Explore more
Paid clinical trials in Indianapolis, IN · Indiana clinical trials